MyChesCo on MSN57m
FDA Grants Fast Track Designation to PleoPharma’s PP-01 for Cannabis Withdrawal Syndrome
PleoPharma, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to PP-01, the company’s lead investigational asset aimed at mitigating Cannabis ...
4 New Habits That Small Business Owners Can Implement In 2025
I might not have predicted quite this much uncertainty so soon, but nonetheless, 2025 is here and it’s throwing curveballs at every tur ...